VIIBRYD

This brand name is authorized in Brazil, Canada, United States

Active ingredients

The drug VIIBRYD contains one active pharmaceutical ingredient (API):

1 Vilazodone UNII U8HTX2GK8J - VILAZODONE HYDROCHLORIDE

Vilazodone is a selective serotonin reuptake inhibitor and a 5HT1A receptor partial agonist. It is used for the treatment of major depressive disorder (MDD) in adults. The mechanism of action of vilazodone in the treatment of major depressive disorder is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the CNS through selective inhibition of serotonin reuptake. Read about Vilazodone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VIIBRYD Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AX24	Vilazodone	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX24

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 501018040012502, 501018040012602, 501018040012702, 501018040012802, 501018040012902, 501018040013002, 501018040013102, 501018040013202, 501018040013302, 501018040013402, 501018040013502
Country: CA	Health Products and Food Branch	Identifier(s): 02443724, 02443732, 02443740, 02443759
Country: US	FDA, National Drug Code	Identifier(s): 0456-1110, 0456-1120, 0456-1140, 55154-4624, 55154-4627